Jones Day's focal areas are reflected in the division of its practice management: Gerd Jaekel leads matters in the technology area, where the group assists clients with FRAND-related disputes before the Federal Court of Justice and the Federal Patent Court among other matters. The chemical and pharmaceutical sectors form the second pillar, which is led by Christian Paul; recently, the practice represented various global pharmaceutical companies in nullity and opposition proceedings.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
'Very good technical knowledge.'
'Gerd Jaekel: Very good technical understanding. Pragmatic assessment of risks.'
Key clients
- Akebia Therapeutics, Inc.
- BioMarin Pharmaceuticals, Inc.
- CJ CheilJedang Corp., Südkorea
- Lufthansa Technik AG
- Astronics
- Panasonic
- Puma Biotechnology, Inc.
- Hope Medical Enterprises, Inc.
- Innio
- Tung Thih Electronic (TTE) Co. Ltd. / Valeo
Work highlights
- Representation of CJ CheilJedang Corp. in a patent dispute over the genetically engineered amino acid tryptophan.
- Represented Puma Biotechnology, Inc. resulting in dismissal of opposition to a European patent covering the use of irreversible inhibitors for the treatment of gefitinib/erlotinib-resistant cancers and cancers harboring the T790M EGFR mutation.
- Representing Lufthansa Technik AG / Astronics, Panasonic and others in a patent infringement lawsuit against a US supplier of cabin electronics.
Practice head
The lawyer(s) leading their teams.
Christian Paul, Gerd Jaekel